CYTOGAM (cytomegalovirus immune globulin (human))
CYTOMEGALOVIRUS (CMV) IMMUNE GLOBULIN · PREVENTION OF CMV DISEASE AFTER ORGAN TRANSPLANT
KAMADA LTD.
Drug class
Cytomegalovirus (CMV) Immune Globulin
Cytomegalovirus (CMV) immune globulin refers to a therapeutic class of hyperimmune globulins prepared from pooled human plasma selected for high titers of neutralizing antibodies against cytomegalovirus. Read more about Cytomegalovirus (CMV) Immune Globulin
1 drugs in this class 1 manufacturers
Drugs in Cytomegalovirus (CMV) Immune Globulin
Filter & compare in the drug finder →
Opens the drug finder with Cytomegalovirus (CMV) Immune Globulin preselected. Add indication or manufacturer filters there.
Cytomegalovirus (CMV) immune globulin refers to a therapeutic class of hyperimmune globulins prepared from pooled human plasma selected for high titers of neutralizing antibodies against cytomegalovirus.
It provides targeted passive immunity by binding and neutralizing viral particles, thereby reducing viral load and mitigating CMV-mediated cellular damage.
Clinically, this biologic class is primarily used for the prophylaxis and attenuation of cytomegalovirus disease in immunosuppressed individuals, most notably solid organ transplant recipients (such as kidney, lung, liver, pancreas, and heart).
In clinical practice, it is often administered either alone or in combination with antiviral therapies to protect high-risk patient populations, such as seronegative recipients receiving organs from seropositive donors.
-
fda.gov
Cytomegalovirus (CMV) immune globulin refers to a therapeutic class of hyperimmune globulins prepared from pooled human plasma selected for high titers of neutralizing antibodies against cytomegalovirus
-
drugs.com
Cytomegalovirus (CMV) immune globulin refers to a therapeutic class of hyperimmune globulins prepared from pooled human plasma selected for high titers of neutralizing antibodies against cytomegalovirus In clinical practice, it is often administered either alone or in combination with antiviral therapies to protect high-risk patient populations, such as seronegative recipients receiving organs from seropositive donors
-
nih.gov
It provides targeted passive immunity by binding and neutralizing viral particles, thereby reducing viral load and mitigating CMV-mediated cellular damage
-
mims.com
It provides targeted passive immunity by binding and neutralizing viral particles, thereby reducing viral load and mitigating CMV-mediated cellular damage
-
fda.gov
Clinically, this biologic class is primarily used for the prophylaxis and attenuation of cytomegalovirus disease in immunosuppressed individuals, most notably solid organ transplant recipients (such as kidney, lung, liver, pancreas, and heart) In clinical practice, it is often administered either alone or in combination with antiviral therapies to protect high-risk patient populations, such as seronegative recipients receiving organs from seropositive donors
-
fda.gov
Clinically, this biologic class is primarily used for the prophylaxis and attenuation of cytomegalovirus disease in immunosuppressed individuals, most notably solid organ transplant recipients (such as kidney, lung, liver, pancreas, and heart)
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.